印度
ANTILA LIFESCIENCES PVT. LTD
会员限时活动
1580
元/年
企业联系人
详细交易记录
实时最新数据
交易概况
总交易额
257,309.88
交易次数
18
平均单价
14,294.99
最近交易
2025/06/27
ANTILA LIFESCIENCES PVT. LTD 贸易洞察 (供应商)
过去5年,ANTILA LIFESCIENCES PVT. LTD在印度市场展现出 交易非常活跃,今年已有多笔成交。 总交易额达 257,309.88 ,累计 18 笔交易。 平均单价 14,294.99 ,最近一次交易于 2025/06/27。
贸易记录
| 日期 | 交易公司 | 交易描述 | 数量 | 金额 |
|---|---|---|---|---|
| 2025-03-03 | SUPERIOR PHARMACEUTICAL LTD | Other medicaments not else where specified | 未公开 | 19129.18 |
| 2025-05-26 | NEXTGEN PHARMACEUTICALS (K) LIMITED | LEBAC DRY SYRUP; CEFUROXIME AXETIL 125MG/5ML; CT; 3000; 125MG/5ML; THERAPEUTIC; 0.00375; H; 1; MEDICAMENTS CONTAINING PENICILLINS OR DERIVATIVES THEREOF, WITH A PENICILLANIC ACID STRUCTURE, OR STREPTOMYCINS OR THEIR DERIVATIVES, PUT UP IN MEASURED DO... | 158.70KGM | 3990.00USD |
| 2025-04-11 | KESSINGTON GLOBAL SYNERGY LTD | Other medicaments not else where specified | 未公开 | 44085.17 |
| 2025-02-21 | NEXTGEN PHARMACEUTICALS (K) LIMITED | AVOLAC SOLUTION; LACTULOSE 3.35GM/5ML; CT; 15100; 3.35MG/5ML; THERAPEUTIC; 0.003 OTHER MEDICAMENTS (EXCLUDING GOODS OF HEADING 30.02, 30.05 OR 30.06) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSE... | 2438.65KGM | 14855.92USD |
| 2025-02-21 | NEXTGEN PHARMACEUTICALS (K) LIMITED | CT; 24912; 750MG; THERAPEUTIC; 0.03949; H; 1; LEBAC 750; CEFUROXIME INJECTION US MEDICAMENTS CONTAINING PENICILLINS OR DERIVATIVES THEREOF, WITH A PENICILLANIC ACID STRUCTURE, OR STREPTOMYCINS OR THEIR DERIVATIVES, PUT UP IN MEASURED DOSES OR IN FORMS... | 1295.42KGM | 13639.44USD |
| 2025-03-03 | SUPERIOR PHARMACEUTICAL LTD | Other medicaments not else where specified | 未公开 | 4240.65 |
贸易国家分析
HS编码情报
| HS编码 | 产品描述 | 频次 |
|---|---|---|
| 854140 | 光电二极管、晶体管、类似半导体器件 | 42 |
| 847130 | 便携式数字处理设备 | 35 |
| 851762 | 无线网络接入设备 | 28 |
| 847330 | 电子计算机零件 | 22 |
| 852910 | 天线和天线反射器 | 18 |
| 853400 | 印刷电路板 | 15 |